Elena C - Search Results

1

Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages.

Bellora F, Dondero A, Corrias MV, Casu B, Regis S, Caliendo F, Moretta A, Cazzola M, Elena C, Vinti L, Locatelli F, Bottino C, Castriconi R. Bellora F, et al. Among authors: elena c. J Immunol. 2017 Aug 15;199(4):1516-1525. doi: 10.4049/jimmunol.1601695. Epub 2017 Jul 12. J Immunol. 2017. PMID: 28701512

2

Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.

Lübke J, Schwaab J, Christen D, Elberink HO, Span B, Niedoszytko M, Gorska A, Lange M, Gleixner KV, Hadzijusufovic E, Solomianyi O, Angelova-Fischer I, Zanotti R, Bonifacio M, Bonadonna P, Shoumariyeh K, von Bubnoff N, Müller S, Perkins C, Elena C, Malcovati L, Hagglund H, Mattsson M, Parente R, Varkonyi J, Fortina AB, Caroppo F, Zink A, Brockow K, Breynaert C, Bullens D, Yavuz AS, Doubek M, Sabato V, Schug T, Niederwieser D, Hartmann K, Triggiani M, Gotlib J, Hermine O, Arock M, Kluin-Nelemans HC, Panse J, Sperr WR, Valent P, Reiter A, Jawhar M. Lübke J, et al. Among authors: elena c. J Allergy Clin Immunol Pract. 2023 Feb;11(2):581-590.e5. doi: 10.1016/j.jaip.2022.10.051. Epub 2022 Nov 17. J Allergy Clin Immunol Pract. 2023. PMID: 36403897

3

Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.

Zambrotta GPM, Nicolini FE, Assouline S, Busque L, Pungolino E, Abruzzese E, Miggiano MC, Elena C, Alvarez-Larran A, Triguero A, Iurlo A, Bucelli C, Cerrano M, Capodanno I, Lunghi F, le Coutre P, Galimberti S, Caocci G, Maffioli M, Stagno F, Saussele S, Piazza R, Druker BJ, Fava C, Guglielmana V, Colombo F, Antolini L, Gambacorti-Passerini C. Zambrotta GPM, et al. Among authors: elena c. Am J Hematol. 2023 Nov;98(11):1762-1771. doi: 10.1002/ajh.27073. Epub 2023 Aug 30. Am J Hematol. 2023. PMID: 37647134

4

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

Rumi E, Passamonti F, Pietra D, Della Porta MG, Arcaini L, Boggi S, Elena C, Boveri E, Pascutto C, Lazzarino M, Cazzola M. Rumi E, et al. Among authors: elena c. Cancer. 2006 Nov 1;107(9):2206-11. doi: 10.1002/cncr.22240. Cancer. 2006. PMID: 16998940 Free article.

5

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.

Boveri E, Passamonti F, Rumi E, Pietra D, Elena C, Arcaini L, Pascutto C, Castello A, Cazzola M, Magrini U, Lazzarino M. Boveri E, et al. Among authors: elena c. Br J Haematol. 2008 Jan;140(2):162-8. doi: 10.1111/j.1365-2141.2007.06885.x. Epub 2007 Nov 19. Br J Haematol. 2008. PMID: 18028479 Free article.

6

Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.

Rumi E, Harutyunyan A, Elena C, Pietra D, Klampfl T, Bagienski K, Berg T, Casetti I, Pascutto C, Passamonti F, Kralovics R, Cazzola M. Rumi E, et al. Among authors: elena c. Am J Hematol. 2011 Dec;86(12):974-9. doi: 10.1002/ajh.22166. Epub 2011 Sep 22. Am J Hematol. 2011. PMID: 21953568 Free article.

7

Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm.

Rumi E, Casetti I, Pietra D, Elena C, Ambaglio I, Pascutto C, Passamonti F, Cazzola M; AGIMM Investigators. Rumi E, et al. Among authors: elena c. Am J Hematol. 2012 Jan;87(1):129-30. doi: 10.1002/ajh.22194. Epub 2011 Oct 31. Am J Hematol. 2012. PMID: 22038760 Free article. No abstract available.

8

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Molteni E, Bono E, Gallì A, Elena C, Ferrari J, Fiorelli N, Pozzi S, Ferretti VV, Sarchi M, Rizzo E, Camilotto V, Boveri E, Cazzola M, Malcovati L. Molteni E, et al. Among authors: elena c. Blood. 2023 Aug 17;142(7):643-657. doi: 10.1182/blood.2022019304. Blood. 2023. PMID: 37216690 Free PMC article.

9

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, Scapin M, Arcaini L, Tezza F, Moratti R, Pascutto C, Fabris F, Morra E, Cazzola M, Lazzarino M. Passamonti F, et al. Among authors: elena c. Blood. 2007 Jul 15;110(2):485-9. doi: 10.1182/blood-2007-01-071068. Epub 2007 Apr 10. Blood. 2007. PMID: 17426257 Free article.

10

Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

Rumi E, Passamonti F, Della Porta MG, Elena C, Arcaini L, Vanelli L, Del Curto C, Pietra D, Boveri E, Pascutto C, Cazzola M, Lazzarino M. Rumi E, et al. Among authors: elena c. J Clin Oncol. 2007 Dec 10;25(35):5630-5. doi: 10.1200/JCO.2007.12.6896. Epub 2007 Nov 12. J Clin Oncol. 2007. PMID: 17998545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page